Skip to main content
. 2021 Mar 8;13(5):1163. doi: 10.3390/cancers13051163

Table 1.

Patient and tumor characteristics by tumor type.

Parameter Total (N = 333) Non-NPC (N = 189) NPC (N = 144)
Age (N = 314)
Median (min, max) 60.2 (14.3, 88.3) 64.9 (37.1, 88.3) 51.6 (14.3, 81.5)
N (%) N (%) N (%)
Sex (N = 333)
Female 52 (15.6) 16 (8.5) 36 (24.8)
Male 282 (84.4) 173 (91.5) 109 (75.2)
Alcohol Abuse (N = 292)
No 145 (49.7) 47 (26.6) 98 (85.2)
Yes 147 (50.3) 130 (73.4) 17 (14.8)
Smoking (N = 293)
No 60 (20.5) 19 (10.8) 41 (35.0)
Yes 233 (79.5) 157 (89.2) 76 (65.0)
Histological Type (N = 307)
Non-Keratinizing Carcinoma 37 (12.1) 0 (0.0) 37 (28.7)
Squamous Cell Carcinoma 189 (61.6) 172 (96.6) 17 (13.2)
Undifferentiated Carcinoma 77 (25.1) 2 (1.1) 75 (58.1)
Other 4 (1.3) 4 (2.2) 0 (0.0)
Primary Tumor Location (N = 318)
Hypopharynx 1 (0.3) 1 (0.57) 0 (0.0)
Larynx 149 (46.9) 149 (85.6) 0 (0.0)
Major Salivary Glands 2 (0.6) 2 (1.1) 0 (0.0)
Nasopharynx 144 (45.3) 0 (0.0) 144 (100.0)
Oral Cavity 11 (3.5) 11 (6.3) 0 (0.0)
Oropharynx 7 (2.2) 7 (4.0) 0 (0.0)
Paranasal Sinuses 4 (1.3) 4 (2.3) 0 (0.0)
T (N = 272)
T1 45 (16.5) 19 (11.3) 26 (25.0)
T2 79 (29.0) 34 (20.2) 45 (43.3)
T3 94 (34.6) 77 (45.8) 17 (16.3)
T4 54 (19.9) 38 (22.6) 16 (15.4)
N (N = 275)
N0 126 (45.8) 114 (67.1) 12 (11.4)
N1 42 (15.3) 14 (8.2) 28 (26.7)
N2 80 (29.1) 33 (19.4) 47 (44.8)
N3 23 (8.4) 5 (2.9) 18 (17.1)
Nx 4 (1.5) 4 (2.4) 0 (0.0)
Stage (N = 281)
I 19 (6.8) 15 (9.0) 4 (3.5)
II 52 (18.5) 23 (13.8) 29 (25.4)
III 105 (37.4) 61 (36.5) 44 (38.6)
IV 105 (37.4) 68 (40.7) 37 (32.5)
Surgery (N = 176)
No 33 (18.8) 33 (18.8) -
Yes 143 (81.3) 143 (81.3) -
Type of Surgery (N = 142)
Chordectomy 8 (5.6) 8 (5.6) -
Hemiglossectomy 5 (3.5) 5 (3.5) -
Hemiglossectomy and Laryngectomy 2 (1.4) 2 (1.4) -
Laryngectomy 113 (79.6) 113 (79.6) -
Other 14 (9.9) 14 (9.9) -
Treatment Received (N = 311)
No 44 (14.1) 43 (23.9) 1 (0.8)
Yes 267 (85.9) 137 (76.1) 130 (99.2)
Type of First Treatment Received (N = 267)
Induction Chemotherapy 10 (3.8) 0 (0.0) 10 (7.7)
Primary concomitant CT and RT 179 (67.0) 65 (47.4) 114 (87.7)
Primary RT 34 (12.7) 33 (24.1) 1 (0.8)
RT after First Progression 1 (0.4) 1 (0.7) 0 (0.0)
Adjuvant 32 (12.0) 29 (21.2) 3 (2.3)
First-Line 11 (4.1) 9 (6.6) 2 (1.5)

The percentages for the type of surgery and the type of primary treatment were calculated from the total number of patients with available data that had undergone surgery and had received treatment, respectively.